U.S. pharma giant copyright scrapped two experimental weight loss products previous yr—a as soon as-each day tablet, lotiglipron, because of elevated liver enzymes and also a 2 times-everyday pill, danuglipron, due to strong Unintended effects—but CEO Albert Bourla has said the compa